MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-11-2026
Harrow Health DPO Ratio 2011-2026 | HROW
Annual DPO Ratio Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 199 | 235 | 177 | 145 | 111 | 99.2 | 161 | 138 | 105 | 131 | 239 | 263 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 263 | 99.2 | 167 |
Quarterly DPO Ratio Harrow Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 109 | 170 | 223 | - | 201 | 156 | 195 | - | 161 | 165 | 165 | - | 158 | 111 | 100 | - | 116 | 116 | 130 | - | 117 | 135 | 167 | - | 191 | 148 | 182 | - | 154 | 155 | 132 | - | 126 | 130 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 223 | 100 | 149 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
38 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
4.75 K | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
889 | $ 5.57 | 0.73 % | $ 82.7 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.71 | 1.31 % | $ 1.04 B |  Canada |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Bausch Health Companies
BHC
|
78.1 | $ 5.41 | -1.73 % | $ 1.97 B | Canada |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.61 | 2.16 % | $ 331 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 23.16 | 0.7 % | $ 1.07 B | USA |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.05 | 1.94 % | $ 113 M | Canada |
 |
Aurora Cannabis
ACB
|
-807 | $ 3.49 | 0.58 % | $ 191 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 1.04 | -2.8 % | $ 1.29 M | USA |
 |
Jupiter Wellness
JUPW
|
318 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Tilray
TLRY
|
53 | $ 5.32 | -1.66 % | $ 3.29 B | Canada |
 |
Evolus
EOLS
|
59.4 | $ 6.53 | -0.91 % | $ 421 M | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.24 | 1.17 % | $ 422 M | USA |
 |
Veru
VERU
|
251 | $ 2.15 | -0.92 % | $ 31.5 M | USA |
 |
cbdMD
YCBD
|
68.6 | $ 0.73 | -0.24 % | $ 2.94 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 23.43 | -0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
274 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.67 | 0.34 % | $ 33.5 M | USA |
 |
Viatris
VTRS
|
70.9 | $ 16.32 | -1.65 % | $ 19 B | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
15.4 | $ 0.8 | -2.52 % | $ 28.8 M | USA |
 |
China Pharma Holdings
CPHI
|
47.6 | $ 0.73 | -2.98 % | $ 3.13 M |  China |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.11 | 1.35 % | $ 24.4 M | USA |